Antiphospholipid syndrome;Syndrome des anticorps anti-phospholipides

Revue du Praticien

Volumn 48, Issue 6, 1998, Pages 626-631

  Disdier, Patrick ^a   Weiller, Pierre Jean ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; FETUS WASTAGE; FRANCE; HUMAN; LUNG EMBOLISM; PATHOPHYSIOLOGY; THROMBOPHLEBITIS; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HUMANS;

EID: 0032520978     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Soulier JP, Boffa MC. Avortements à répétition, thromboses, anticoagulant circulant Nouv Presse Med 1980; 9: 859-65.
2. Harris EN, Baguley E, Asherson RA, Hughes GRV. Clinical and serological features of the "antiphospholipid syndrome". Br J Rheumatol 1987; 26 (suppl 2): 19.
3. Alarcon-Segovia D, Perez-Vasquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Sem Arthritis Rheum 1992; 21: 275-85.
4. Piette JC. 1996 diagnosis and classification criteria for the antiphospholipid/cofactors syndrome: a "mission impossible"? Lupus 1996; 5: 354-63.
5. Piette JC, Wechsler B, Frances C et al. Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol 1993; 20: 1802-4.
6. Anonymous. Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. The Antiphospholipid antibodies and Stroke Study Group (APASS). Neurology 1997; 48: 91-4.
7. Silvestrini M, Matteis M, Troisi E, Cupini LM, Zaccari G, Bernardi G. Migrainous stroke and the antiphospholipid antibodies. Eur Neurol 1994; 34: 316-9.
8. Disdier P, Christides C, Andrac-Meyer L et al. L'anétodermie au cours du syndrome des antiphospholipides. Ann Dermatol Venereol 1996; 123: 800-3.
9. Working Group on Hemostasis of the Société Française de Biologie Clinique. Comparison of a standardized procedure with current laboratory practices for the detection of lupus anticoagulant in France. Thromb Haemost 1993; 70: 781-6.
10. Disdier P, Swiader L, Aillaud MF, Harlé JR, Weiller PJ. Familial Mediterranean fever crisis and lupus anticoagulant. Lancet 1996; 348: 1321-2.
11. Ziporen L, Shoenfeld Y, Lévy Y, Korezyn AD. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest 1997; 100: 613-9.
12. Cuadrado MJ, Lopez-Pedrera C, Khamashta MA et al. Thrombosis in primary antiphospholipid syndrome. A pivotal role for monocyte tissue factor expression. Arthritis Rheum 1997; 40: 834-41.
13. Roubey RAS. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996; 39: 1444-54.
14. Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997; 127: 177-85.
15. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid syndrome. N Engl J Med 1995; 332: 993-7.
16. e édition. Paris : Flammarion Médecine-Science. 1996: 125-9.